136 related articles for article (PubMed ID: 7227851)
1. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay.
Hawkey CJ; Truelove SC
Gut; 1981 Mar; 22(3):190-3. PubMed ID: 7227851
[TBL] [Abstract][Full Text] [Related]
2. Evidence that prednisolone is inhibitory to the cyclooxygenase activity of human rectal mucosa.
Hawley CJ
Prostaglandins; 1982 Mar; 23(3):397-409. PubMed ID: 6808592
[TBL] [Abstract][Full Text] [Related]
3. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
Sharon P; Ligumsky M; Rachmilewitz D; Zor U
Gastroenterology; 1978 Oct; 75(4):638-40. PubMed ID: 30669
[TBL] [Abstract][Full Text] [Related]
4. Flufenamic acid inhibition of PGE2 production by rectal mucosa in ulcerative colitis.
Rachmilewitz D; Ligumsky M; Sharon P; Karmeli F; Zor U
Gastroenterology; 1978 Nov; 75(5):929-30. PubMed ID: 29819
[No Abstract] [Full Text] [Related]
5. In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.
Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
Gut; 1987 Sep; 28(9):1095-9. PubMed ID: 2824300
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of prostaglandin synthetase in human rectal mucosa.
Hawkey CJ; Lo Casto M
Gut; 1983 Mar; 24(3):213-7. PubMed ID: 6131017
[TBL] [Abstract][Full Text] [Related]
7. Verapamil inhibits in-vitro leucotriene B4 release by rectal mucosa in active ulcerative colitis.
Gertner DJ; Rampton DS; Stevens TR; Lennard-Jones JE
Aliment Pharmacol Ther; 1992 Apr; 6(2):163-8. PubMed ID: 1318088
[TBL] [Abstract][Full Text] [Related]
8. Relationship between rectal mucosal prostaglandin production and water and electrolyte transport in ulcerative colitis.
Rampton DS; Sladen GE
Digestion; 1984; 30(1):13-22. PubMed ID: 6149163
[TBL] [Abstract][Full Text] [Related]
9. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine.
Ligumsky M; Karmeli F; Sharon P; Zor U; Cohen F; Rachmilewitz D
Gastroenterology; 1981 Sep; 81(3):444-9. PubMed ID: 6114012
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis.
Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
Gastroenterology; 1986 Oct; 91(4):837-44. PubMed ID: 3017804
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease: the in vitro effect of sulphasalazine and other agents on prostaglandin synthesis by human rectal mucosa.
Pacheco S; Hillier K; Smith CL
Braz J Med Biol Res; 1987; 20(2):221-30. PubMed ID: 2891390
[TBL] [Abstract][Full Text] [Related]
12. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.
Eliakim R; Karmeli F; Razin E; Rachmilewitz D
Gastroenterology; 1988 Nov; 95(5):1167-72. PubMed ID: 2901995
[TBL] [Abstract][Full Text] [Related]
13. Rectal mucosal prostaglandin E release and electrolyte transport in ulcerative colitis.
Rampton DS; Sladen GE; Bhakoo KK; Heinzelmann DI; Youlten LJ
Adv Prostaglandin Thromboxane Res; 1980; 8():1621-5. PubMed ID: 7377010
[No Abstract] [Full Text] [Related]
14. The effect of sulphasalazine withdrawal on rectal mucosal function and prostaglandin E2 release in inactive ulcerative colitis.
Rampton DS; Sladen GE
Scand J Gastroenterol; 1981; 16(1):157-9. PubMed ID: 6112788
[TBL] [Abstract][Full Text] [Related]
15. Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.
Rampton DS; Sladen GE; Youlten LJ
Gut; 1980 Jul; 21(7):591-6. PubMed ID: 7429322
[TBL] [Abstract][Full Text] [Related]
16. [Local production of eicosanoids in patients with ulcerative colitis].
Lukás K; Lukás M; Jáchymová M
Cas Lek Cesk; 1995 Jan; 134(1):13-7. PubMed ID: 7712517
[TBL] [Abstract][Full Text] [Related]
17. Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease.
Hawkey CJ; Karmeli F; Rachmilewitz D
Gut; 1983 Oct; 24(10):881-5. PubMed ID: 6578172
[TBL] [Abstract][Full Text] [Related]
18. Mucosal and plasma prostaglandin E2 in ulcerative colitis.
Wiercinska-Drapalo A; Flisiak R; Prokopowicz D
Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993
[TBL] [Abstract][Full Text] [Related]
19. [Prostacyclin (PGI2) activity in the rectal mucosa of patients with ulcerative colitis (author's transl)].
Seyfried H; Sinzinger H; Silberbauer K
Wien Klin Wochenschr; 1980 Apr; 92(8):282-4. PubMed ID: 6773249
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandins and ulcerative colitis.
Rampton DS; Sladen GE; Youlten LJ
Gastroenterology; 1980 Jan; 78(1):192-3. PubMed ID: 7350029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
